Fletcher Spaght Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Consulting

Industry

Estimated Revenue & Valuation

  • Fletcher Spaght's estimated annual revenue is currently $6M per year.(i)
  • Fletcher Spaght's estimated revenue per employee is $187,000

Employee Data

  • Fletcher Spaght has 32 Employees.(i)
  • Fletcher Spaght grew their employee count by 0% last year.

Fletcher Spaght's People

NameTitleEmail/Phone
1
SVPReveal Email/Phone
2
SVPReveal Email/Phone
3
PartnerReveal Email/Phone
4
PartnerReveal Email/Phone
5
Executive AssistantReveal Email/Phone
6
Managing PartnerReveal Email/Phone
7
Associate ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.3M24120%N/AN/A
#2
$924.6M3002-1%N/AN/A
#3
$16.9M7745%N/AN/A
#4
$19.4M881%N/AN/A
#5
$72.6M3003%N/AN/A
#6
$7.6M438%N/AN/A
#7
$3.7M24-17%N/AN/A
#8
$39.2M1629%N/AN/A
#9
$3.7M244%N/AN/A
#10
$30.4M138N/AN/AN/A
Add Company

What Is Fletcher Spaght?

Fletcher Spaght Ventures, L.P. (FSV) is a venture capital fund investing in emerging growth high technology and healthcare companies. Established to build substantial, long-term capital appreciation, FSV invests in companies with: Familiarity/experience with the company. Promising business potential. Financing led by top-tier venture capital firm. Included are companies in the areas of information technology (IT) and IT services, Internet, software, telecommunications, medical devices, healthcare informatics, biotechnology and healthcare services.

keywords:N/A

N/A

Total Funding

32

Number of Employees

$6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Fletcher Spaght News

2013-10-25 - Roundup: Swift Biosciences Raises $7M Round, Free Wi-fi Now in Downtown Detroit

Share Share on Facebook Share on Twitter LinkedIn Email Reprints Here’s a look at news from around Southeast Michigan’s innovation community: —Ann Arbor-based Swift Biosciences announced this week that it has raised a $7 million Series B round. Fletcher Spaght Ventures led the round, and the R ...

2013-10-18 - Swift Biosciences Raises $7M in Series B Financing

Swift Biosciences, an Ann Arbor, Michigan-based developer of technologies for genomics and personalized medicine, raised $7m in Series B financing. The round was led by Fletcher Spaght Ventures with participation from Renaissance Venture Capital Fund, the Mercury Fund, Michigan Accelerator Fund ...

2012-08-21 - Type 2 diabetes drug with goal of 24/7 glycemic control begins Phase 2b trial

The biotechnology firm raised $48.4 million earlier this year in its third tranche for its series B financing round led by New Enterprise Associates with participation by Hatteras Venture Partners, Johnson & Johnson Development Corp., Astellas Venture Management and Fletcher Spaght Ventures. Th ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.3M32-32%N/A
#2
$3.3M32-24%N/A
#3
$8.3M320%N/A
#4
$4.2M323%N/A
#5
$3.5M3223%$14M